Sage Journals: Discover world-class research

Free access

Research article

First published 2020

Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis

T.J.S. Bekooij, H.J. Gilhuis, L. Dawson [...]

Journal of Neuromuscular Diseases

Retricted access

Case report

First published 2025

Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report

Hamza Maqsood, James Fleming

The Neurohospitalist

Open access

Letter

First published 2017-10

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience

Christiane Schneider-Gold, Anke Reinacher-Schick, Gisa Ellrichmann [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2024

Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised,double-blind,placebo-controlled,adaptive phase III MycarinG study

Ali A. Habib, Sabrina Sacconi, Giovanni Antonini [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2025

Syncope as a Presenting Symptom of MuSK-Associated Myasthenia Gravis: A Case Report

Danielle Akinsanmi, Roshan Srinivasan, Yaacov Anziska [...]

Journal of Child Neurology

Open access

Review article

First published 2025

National guidelines for diagnosis,treatment,and management of myasthenia gravis in Israel

Shahar Shelly, Marc Gotkine, Adi Wilf Yarkoni [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2026

Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study

Qian Zhou, Yuzhen Ouyang, Fei Jiang [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2025

Consensus guidelines on the diagnosis and management of myasthenia gravis by the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine and neuromuscular specialists from the Gulf Cooperation Council region

Ali Mohammed Alshehri, Mohammed H. Alanazy, Majed Alabdali [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025-3

Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension

Ali A Habib, Artur Drużdż, Julian Grosskreutz [...]

Journal of Neuromuscular Diseases

Open access

Research article

First published 2025

Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis

Yufan Zhou, Qian Zhou, Yaoxian Yue [...]

Therapeutic Advances in Neurological Disorders

Search results